| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | WO2003062392A3 Methods of treating conditions associated with an edg receptor |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014847 Ambroxol for the treatment of chronic nociceptive pain |
| 01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
| 01/20/2005 | US20050014832 Treatment |
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014801 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/20/2005 | US20050014776 Steroidal compounds for inhibiting steroid sulphatase |
| 01/20/2005 | US20050014768 Antiinflammatory agents; analgesics |
| 01/20/2005 | US20050014753 Antitumor agents |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/20/2005 | US20050014726 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol |
| 01/20/2005 | US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014703 Cell differentiation, regeneration of epithelium pancreas cells into insulin producing beta-cells; administrering a peptidyl- peptidase activator |
| 01/20/2005 | US20050014701 Synergistic mixture; anticoagulants |
| 01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050013859 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | US20050013814 Methods for treating rheumatoid arthritis using IL-17 antagonists |
| 01/20/2005 | DE20221087U1 Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen Transdermal therapeutic system with fentanyl and related substances |
| 01/20/2005 | CA2531749A1 N-(heterobicycloalkanes)-subtituted indoles- or heteroderivatives thereof |
| 01/20/2005 | CA2531629A1 Medicinal composition containing nf-.kappa.b decoy for treating and preventing respiratory diseases and method of using the same |
| 01/20/2005 | CA2528626A1 Indoles useful in the treatment of inflammation |
| 01/19/2005 | EP1498491A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO Fc GAMMA RECEPTOR IIIa |
| 01/19/2005 | EP1498490A1 Process for producing antibody composition |
| 01/19/2005 | EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1498119A1 Use of conjugated linoleic acid for treating colds |
| 01/19/2005 | EP1497327A2 Method for the identification of inhibitors of the binding of are-containing mrna and an hur protein |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1497297A1 Polymorph of ascomycin derivative |
| 01/19/2005 | EP1497289A1 Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 01/19/2005 | EP1497285A1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 01/19/2005 | EP1497280A1 Indol-2-ones as selective inhibitors of cyclooxygenase-2 |
| 01/19/2005 | EP1497278A1 Heterocyclic amide derivatives as cytokine inhibitors |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496941A1 Glycodendrimers having biological activity |
| 01/19/2005 | EP1496930A2 G-type peptides to ameliorate atherosclerosis |
| 01/19/2005 | EP1496921A1 Preparation containing a mixture of picrorrhiza and ginkgo for the relief of disease |
| 01/19/2005 | EP1496917A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 01/19/2005 | EP1496914A1 (20S)-1a-HYDROXY-2a-METHYL AND 2&bgr;-METHYL-19-NOR-VITAM IN D sb 3 /sb AND THEIR USES |
| 01/19/2005 | EP1496911A1 Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496907A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496904A1 Pharmaceutical containing n, n'-disubstituted piperazine compounds |
| 01/19/2005 | EP1496902A1 Medicaments containing steroids and a novel anticholinesterase drug |
| 01/19/2005 | EP1496901A2 Compositions comprising mmp7 modulators for the treatment of chronic pain |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496894A1 Angiogenesis inhibitors |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496890A1 Substituted beta-aminoalcohols used as medicaments |
| 01/19/2005 | EP1496883A1 Method for treating ileus with an alpha-ketoalkanoic acid, ester or amide |
| 01/19/2005 | EP1496878A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 01/19/2005 | EP1496873A2 Chewable soft capsule |
| 01/19/2005 | EP1496857A1 Aerosol containing a particulate active substance |
| 01/19/2005 | EP1496835A2 Compositions and methods for systemic inhibition of cartilage degradation |
| 01/19/2005 | EP1496834A2 High affinity integrin polypeptides and uses thereof |
| 01/19/2005 | EP1395268B1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation |
| 01/19/2005 | EP1392366A4 Nuclear receptor-mediated introduction of a pna into cell nuclei |
| 01/19/2005 | EP1385510A4 Prodigiosin composition for the treatment of rheumatic arthritis |
| 01/19/2005 | EP1377574B1 6-phenylbenzonaphthyridines |
| 01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 01/19/2005 | EP1208104B1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/19/2005 | EP1063228B1 Cycloalkene derivatives, process for producing the same, and use |
| 01/19/2005 | EP0994880B1 Crystalline macrolides and process for their preparation |
| 01/19/2005 | CN1568331A Biological products |
| 01/19/2005 | CN1568330A Glycosylphosphatidylinositol containing polypeptides |
| 01/19/2005 | CN1568323A Activator for peroxisome proliferator-activated receptor delta |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/19/2005 | CN1568320A 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 01/19/2005 | CN1568309A 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/19/2005 | CN1568307A Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 01/19/2005 | CN1568306A Hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/19/2005 | CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines |
| 01/19/2005 | CN1568193A Use of il-18 inhibitors in hypersensitivity disorders |
| 01/19/2005 | CN1568188A Nociceptin analogs |
| 01/19/2005 | CN1568181A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
| 01/19/2005 | CN1566136A Pasqueflower notoginsenosides and extraction method, medicinal uses and pharmaceutical preparation thereof |
| 01/19/2005 | CN1566124A Cornel extract and use thereof |
| 01/19/2005 | CN1566107A Extraction method of baicalin element and application in antiinflammation and ease pain thereof |